UA120763U - MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL" - Google Patents
MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL"Info
- Publication number
- UA120763U UA120763U UAU201708005U UAU201708005U UA120763U UA 120763 U UA120763 U UA 120763U UA U201708005 U UAU201708005 U UA U201708005U UA U201708005 U UAU201708005 U UA U201708005U UA 120763 U UA120763 U UA 120763U
- Authority
- UA
- Ukraine
- Prior art keywords
- drug
- spasmolitic
- promedol
- action
- medicinal product
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Лікарський препарат знеболювальної та спазмолітичної дії включає сполуку за формулою І: EMBED ISISServer , (I) причому лікарський препарат застосовується у формі розчину для ін'єкцій в концентрації 20,0 мг/мл по 1 мл в ампулах, причому кожна ампула містить 20,0 мг сполуки за формулою І, де ампула виготовлена з хімічно стійкого матеріалу, за умови, що лікарський препарат по суті вільний від іонів двовалентних металів, допоміжні речовини вибирають як щонайменше одну речовину з ряду взаємозамінюваних речовин: натрію хлорид, вода для ін'єкцій, етиловий спирт, а період напіввиведення препарату складає від 1 до 4 годин.An analgesic and antispasmodic drug comprises a compound of the formula I: EMBED ISISServer, (I) wherein the drug is administered as a solution for injection at a concentration of 20.0 mg / ml per 1 ml in ampoules, each ampoule containing 20.0 mg of a compound of formula I wherein the ampoule is made of a chemically stable material, provided that the drug is substantially free of divalent metal ions, the excipients are selected as at least one substance from a number of interchangeable substances: sodium chloride, water for injection, ethyl dispute And the half-life of the drug is from 1 to 4 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708005U UA120763U (en) | 2017-08-01 | 2017-08-01 | MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL" |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708005U UA120763U (en) | 2017-08-01 | 2017-08-01 | MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA120763U true UA120763U (en) | 2017-11-10 |
Family
ID=60258668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201708005U UA120763U (en) | 2017-08-01 | 2017-08-01 | MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL" |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA120763U (en) |
-
2017
- 2017-08-01 UA UAU201708005U patent/UA120763U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2356547C2 (en) | Cancer therapy with using hdac inhibitors | |
| RU2010133489A (en) | USE OF GAMMA SECRETASE INHIBITORS FOR TREATMENT OF CANCER | |
| EA201690069A1 (en) | THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE | |
| EA201270144A1 (en) | COMBINED THERAPY FOR TREATMENT OF DIABETES | |
| RU2008122358A (en) | MEDICINAL FORMS CONTAINING AG013736 | |
| NZ595767A (en) | Composition for the treatment of prostate cancer | |
| RU2019134416A (en) | PHARMACEUTICAL COMPOSITIONS | |
| RU2012108439A (en) | METHODS FOR TREATING TUMORS OF THE BRAIN | |
| EA200501821A1 (en) | PHARMACEUTICAL COMBINATION, CONTAINING MODAFINIL AND OTHER DRUG PREPARATION | |
| EA201490495A1 (en) | NEW EASY DESTROYING ROCK INHIBITORS | |
| EA201070625A1 (en) | DELIVERY SYSTEM OF MEDICINES FOR THE INTRODUCTION OF WATER-SOLUBLE CATION AND AMFILA PHARMACEUTICAL ACTIVE SUBSTANCE | |
| UA120763U (en) | MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL" | |
| EA201591653A1 (en) | COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL | |
| EA200600377A1 (en) | NEW COMPOSITION | |
| RU2015111491A (en) | COMBINATION OF THE MACROCYCLIC HCV PROTEASE INHIBITOR, HCV NON-NUCLEOSIDE INHIBITOR AND RITONAVIR | |
| RU2010134265A (en) | METHOD FOR TREATING DYSPEPSY IN CALVES | |
| RU2020127436A (en) | Composition for treating a patient suffering from ulcerative colitis and using the composition as a medicine | |
| UA120764U (en) | THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL" | |
| RU2014148062A (en) | INJECTION PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL | |
| UA120761U (en) | MORPHIN MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION | |
| EA199901103A1 (en) | ANTI-VIRUS PREPARATION FOR INJECTIONS | |
| RU2014128528A (en) | Type I and Type II diabetes | |
| EA200801299A1 (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF SOLUTION FOR INJECTION, OWNING CEREBROSODILITATING AND NOOTROPIC ACTIVITY, AND METHOD OF ITS RECEIVING | |
| RU2013127881A (en) | APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment | |
| UA132469U (en) | METHOD OF TREATMENT OF Thyroid Hormone Deficiency |